Literature DB >> 31275868

Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes.

A Deeb1, H Yousef1, N Al Qahtani1, I Artan2, S Suliman1, M Tomy1, L Abdulrahman1, H Al Suwaidi1, S Attia1, N Nagelkerke3.   

Abstract

PURPOSE: Glucose monitoring [GM] is a mainstay of diabetes control and management. Improving glycemic control is essential to prevent microvascular complications. However, adherence to GM can be a challenge in children and adolescents. Detecting hypoglycemia is essential for its prevention and treatment. We aim to study the impact of the flash ambulatory glucose monitoring in detecting hypoglycemia and enhancing adherence in children and adolescents with type 1 diabetes.
METHODS: The study is prospective involving 3 hospital visits. Children and adolescents with diabetes were enrolled in the study which involved a period on conventional glucose self-monitoring [glucometers] followed by a similar period of monitoring using the flash glucose monitoring device (FreeStyle Libre). Frequency of GM, duration and frequency of hypoglycemia were compared on conventional and the flash monitoring.
RESULTS: 75 subjects were studied. Age mean (range) was 11.9 years (2-19). Significant difference was seen in hypoglycemia detection between both testing devices. 68 (94%) and 65 (90%) patients detected nocturnal and diurnal hypoglycemia respectively on Flash monitoring compared to 12 (16.6%) and 30 (41%) on glucometer testing (p < 0.00). Mean (range) duration of hypoglycemia was 95 min (15-330). Statistically-significant difference was found between the frequency of GM on glucometer testing compared with Flash monitoring (2.87 and 11.6/day) (p < 0.001).
CONCLUSIONS: Flash monitoring is a useful tool to improve adherence to GM and detecting hypoglycemia [diurnal and nocturnal] in children and adolescents with type 1 diabetes.

Entities:  

Keywords:  Ambulatory; Flash; Glucose; Hypoglycemia; Libre; Monitoring

Year:  2019        PMID: 31275868      PMCID: PMC6582115          DOI: 10.1007/s40200-018-0351-9

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  35 in total

1.  Long hypoglycaemic periods detected by subcutaneous continuous glucose monitoring in toddlers and pre-school children with diabetes mellitus.

Authors:  D Deiss; O Kordonouri; K Meyer; T Danne
Journal:  Diabet Med       Date:  2001-04       Impact factor: 4.359

2.  Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.

Authors:  Francine Ratner Kaufman; Juliana Austin; Aaron Neinstein; Lily Jeng; Mary Halvorson; Debra J Devoe; Pisit Pitukcheewanont
Journal:  J Pediatr       Date:  2002-11       Impact factor: 4.406

3.  Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.

Authors:  M Schütt; W Kern; U Krause; P Busch; A Dapp; R Grziwotz; I Mayer; J Rosenbauer; C Wagner; A Zimmermann; W Kerner; R W Holl
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-07       Impact factor: 2.949

Review 4.  Hypoglycaemia: current management and controversies.

Authors:  Pratik Choudhary; Stephanie A Amiel
Journal:  Postgrad Med J       Date:  2011-02-04       Impact factor: 2.401

5.  Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

6.  Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.

Authors:  E S Kilpatrick; A S Rigby; K Goode; S L Atkin
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

7.  Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes.

Authors:  Gábor Vincze; Jamie C Barner; Debra Lopez
Journal:  Diabetes Educ       Date:  2004 Jan-Feb       Impact factor: 2.140

Review 8.  Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention.

Authors:  Kate V Allen; Brian M Frier
Journal:  Endocr Pract       Date:  2003 Nov-Dec       Impact factor: 3.443

9.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

10.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

View more
  3 in total

1.  Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile.

Authors:  Bader Alzahrani; Saad Alzahrani; Mussa H Almalki; Souha S Elabd; Shawana Abdulhamid Khan; Badurudeen Buhary; Naji Aljuhani; Anwar A Jammah
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-05-05

Review 2.  Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes.

Authors:  Nancy Elbarbary; Othmar Moser; Saif Al Yaarubi; Hussain Alsaffar; Adnan Al Shaikh; Ramzi A Ajjan; Asma Deeb
Journal:  Diab Vasc Dis Res       Date:  2021 Nov-Dec       Impact factor: 3.291

Review 3.  Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World.

Authors:  Judith L Glennie; Lori Berard; Fleur Levrat-Guillen
Journal:  Clinicoecon Outcomes Res       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.